Roshawn A. Blunt's Net Worth

$0

Estimate Recalculated Nov 1, 2024 04:01AM EST

Who is Roshawn A. Blunt?

Roshawn A. Blunt does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Kronos Bio, Inc., Adamis Pharmaceuticals Corp, and Reneo Pharmaceuticals, Inc..

SEC CIK

Roshawn A. Blunt's CIK is 0001787773

Past Insider Trading and Trends

2022 was Roshawn A. Blunt's most active year for acquiring shares with 2 total transactions. Roshawn A. Blunt's most active month to acquire stocks was the month of May. 2019 saw Roshawn A. Blunt paying a total of $0.00 for 50,000 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Kronos Bio, Inc. (KRON) Snapshot price: $0.9601

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 25
Form 4
—
0
—
—
0
Jun 22
Form 4
—
0
—
—
0
Jun 22
Form 4
—
0
—
—
0
Nov 11
Form 3
—
0
—
—
0
No matching records found

Adamis Pharmaceuticals Corp (DMK) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Aug 26
Form 3
—
0
—
—
0
No matching records found

Reneo Pharmaceuticals, Inc. (RPHM) Snapshot price: $1.43

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
—
—
0
Aug 2
Form 3
—
0
—
—
0
No matching records found